Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-in-Human Phase 1 Single-Ascending Dose Study of ABCL575 in Healthy Participants

NCT07108894 is registered in ClinicalTrials.gov with AbCellera Biologics Inc. as lead sponsor.

NCT NCT07108894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07108894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-in-Human Phase 1 Single-Ascending Dose Study of ABCL575 in Healthy Participants
Lead sponsor
AbCellera Biologics Inc.
Phase
Phase 1
Overall status
Active, not recruiting
Start date
July 25, 2025
Completion date
April 30, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers